Cellectar Biosciences, Inc.
CLRB
$0.2513
$0.00712.91%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/7/2025
-
GuruFocus
5/7/2025
-
GuruFocus
5/7/2025
-
Globe Newswire
4/30/2025
-
GuruFocus
4/30/2025
-
The Fly
4/30/2025
-
Globe Newswire
4/30/2025
-
FierceBiotech.com - Biotech
4/17/2025
-
Zacks Investment Research
3/18/2025
-
Zacks Investment Research
3/14/2025
-
Insider Monkey
3/14/2025
-
GuruFocus
3/14/2025
-
GuruFocus
3/14/2025
-
TipRanks Financial Blog
3/13/2025
-
SeekingAlpha
3/13/2025
-
Seeking Alpha: Transcripts
3/13/2025
-
GuruFocus
3/13/2025
-
The Fly
3/13/2025
-
The Fly
3/13/2025
-
Globe Newswire
3/11/2025
-
GuruFocus
3/11/2025
-
Globe Newswire
3/5/2025
-
GuruFocus
3/5/2025
-
Globe Newswire
2/15/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Oct 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
608 441 8120
Address
100 Campus Drive
Florham Park, NJ 07932
Florham Park, NJ 07932
Country
Year Founded
Business Description
Sector
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The...
more